I now have comprehensive information. Here is a thorough guide on Acute Kidney Injury:
Acute Kidney Injury (AKI)
Definition
AKI is defined by the KDIGO (Kidney Disease: Improving Global Outcomes) criteria as any of the following:
- Rise in serum creatinine ≥0.3 mg/dL within 48 hours, OR
- Rise in serum creatinine to ≥1.5× baseline within 7 days, OR
- Urine output <0.5 mL/kg/h for ≥6 hours
- National Kidney Foundation Primer on Kidney Diseases, 8th Ed.
KDIGO Staging
| Stage | Serum Creatinine Criteria | Urine Output Criteria |
|---|
| 1 | ↑ ≥0.3 mg/dL OR ↑ ×1.5-1.9 from baseline | <0.5 mL/kg/h for 6-12 h |
| 2 | ↑ ×2.0-2.9 from baseline | <0.5 mL/kg/h for ≥12 h |
| 3 | ↑ ×3.0 OR ≥4.0 mg/dL OR initiation of RRT* | <0.3 mL/kg/h for ≥24 h OR anuria ≥12 h |
*In patients <18 years: eGFR <35 mL/min/1.73m² also qualifies for Stage 3.
Patients who receive kidney replacement therapy (KRT) are automatically classified as Stage 3 regardless of their creatinine at the time KRT is started.
Classification by Cause
AKI is classically divided into three anatomical categories:
1. Prerenal AKI (~21% of hospital AKI)
Caused by reduced renal perfusion - GFR falls but the kidney itself is structurally intact initially.
Causes:
- True hypovolemia: hemorrhage, GI losses (vomiting/diarrhea), burns, diuretic overuse
- Reduced cardiac output: congestive heart failure, cardiogenic shock
- Systemic vasodilation: sepsis, liver failure (hepatorenal syndrome), anaphylaxis
- Renal vasoconstriction: NSAIDs, ACE inhibitors/ARBs in the setting of hypotension, contrast nephropathy
Key diagnostic features:
- BUN:Creatinine ratio >20:1
- Urine sodium <20 mEq/L
- FENa <1%
- Urine specific gravity high (concentrated urine)
- Reversible within 24-72 hours of fluid resuscitation/correction
"The hallmark of prerenal disease is its reversibility after treatment of the underlying cause, with absence of structural damage to the kidney if treated promptly." - Campbell-Walsh-Wein Urology
2. Intrinsic (Renal) AKI (~58% of hospital AKI)
Structural damage to the kidney itself.
| Compartment | Disease | Features |
|---|
| Tubules | Acute Tubular Necrosis (ATN) - most common (45%) | Urine Na >40, FENa >1%, muddy brown casts |
| Glomeruli | Glomerulonephritis, TTP/HUS | RBC casts, heavy proteinuria |
| Interstitium | Acute Interstitial Nephritis (AIN) | WBC casts, eosinophilia, drug/infection cause |
| Vessels | Renal artery/vein thrombosis, vasculitis | |
Common causes of ATN:
- Ischemic: Prolonged hypotension, septic shock
- Nephrotoxic drugs: Aminoglycosides, amphotericin B, cisplatin, vancomycin, NSAIDs, contrast agents, cyclosporine, tenofovir
- Endogenous toxins: Myoglobin (rhabdomyolysis), hemoglobin (hemolysis), uric acid (tumor lysis syndrome)
Newer nephrotoxic agents to be aware of:
- Checkpoint inhibitors (nivolumab, pembrolizumab) - cause AIN
- Tyrosine kinase inhibitors (sorafenib, sunitinib) - cause TMA and proteinuria
3. Postrenal AKI (~10% of hospital AKI)
Caused by obstruction at any level of the urinary tract. Requires bilateral obstruction (or unilateral in a solitary kidney) to cause AKI.
Causes:
- Benign prostatic hyperplasia (most common in older men)
- Bilateral ureteral stones
- Pelvic/retroperitoneal malignancy
- Neurogenic bladder
- Strictures
Clinical Features
AKI is often asymptomatic in early stages. Symptoms arise from the metabolic consequences:
- Oliguria (urine output <400 mL/day) or anuria
- Fluid overload: edema, pulmonary edema, hypertension
- Uremic symptoms: nausea, vomiting, hiccups, metallic taste, encephalopathy, asterixis
- Fatigue, decreased appetite
Complications
| System | Complication |
|---|
| Metabolic | Hyperkalemia, metabolic acidosis (↑anion gap), hyponatremia, hypocalcemia, hyperphosphatemia, hyperuricemia, hypermagnesemia |
| Cardiovascular | Pulmonary edema, arrhythmias (from hyperkalemia), pericarditis, pericardial effusion, hypertension, MI |
| Gastrointestinal | Nausea, vomiting, GI hemorrhage, malnutrition |
| Neurologic | Encephalopathy, asterixis, seizures, mental status changes |
| Hematologic | Anemia, uremic bleeding (platelet dysfunction) |
| Infectious | Pneumonia, septicemia, UTI |
- Brenner & Rector's The Kidney, 2-Volume Set
Diagnosis: Key Lab Differentiation
| Test | Prerenal | Intrinsic (ATN) | Postrenal |
|---|
| BUN:Cr ratio | >20:1 | ~10-15:1 | Variable |
| Urine Na (mEq/L) | <20 | >40 | >40 |
| FENa | <1% | >1-2% | >1% |
| Urine osmolality | >500 mOsm/kg | <350 mOsm/kg | Variable |
| Urine specific gravity | >1.020 | ~1.010 (isosthenuric) | Variable |
| Urinary casts | Hyaline casts | Muddy brown granular casts | None or RBC/WBC |
Management
General Supportive Measures
- Treat the underlying cause - fluid resuscitation for hypovolemia, antibiotics for sepsis, relieve obstruction for postrenal
- Stop nephrotoxins - hold ACE inhibitors, ARBs, NSAIDs, contrast agents, aminoglycosides
- Optimize fluid balance - avoid both over- and under-hydration
- Nutrition: KDIGO recommends 20-30 kcal/kg/day; protein 0.8-1.0 g/kg/day (non-dialysis), 1.0-1.5 g/kg/day (dialysis), up to 1.7 g/kg/day (hypercatabolic on CRRT)
- Metabolic acidosis: Treat only if pH <7.20 and HCO₃⁻ <15 mmol/L with IV/oral sodium bicarbonate
- Hyperphosphatemia: Phosphate binders (calcium carbonate, sevelamer, lanthanum)
- DVT prophylaxis - avoid LMWH and factor Xa inhibitors in severe AKI; prefer unfractionated heparin
Renal Replacement Therapy (RRT)
Indications (the "AEIOU" mnemonic):
- A - Acidosis (severe, refractory to bicarbonate)
- E - Electrolytes (hyperkalemia refractory to medical management)
- I - Intoxications (certain toxic ingestions)
- O - Overload (volume/fluid overload refractory to diuretics)
- U - Uremia (asterixis, pericardial rub, encephalopathy, uremic bleeding)
Many nephrologists also initiate dialysis empirically when BUN exceeds ~100 mg/dL without signs of kidney recovery.
RRT modalities:
- Intermittent Hemodialysis (IHD) - standard, for hemodynamically stable patients
- Continuous Renal Replacement Therapy (CRRT) - preferred in septic shock or hemodynamic instability, as it avoids rapid intravascular fluid shifts
- Peritoneal Dialysis - alternative when vascular access is unavailable
"Initiating early RRT has not been demonstrated to improve survival and may increase the risk of adverse events." - Harrison's Principles of Internal Medicine, 22nd Ed.
Prognosis and Long-Term Outcomes
AKI carries significant long-term consequences even after apparent recovery:
- 72.1% of patients who had AKI without pre-existing CKD developed CKD within 2 years
- AKI requiring dialysis is associated with a 3.23× increased incidence of chronic dialysis vs. matched controls
- AKI increases risk of ESKD by 13-fold (no prior CKD) and 41-fold (with prior CKD)
- AKI that required dialysis carries >double the risk of death in the long-term
Recent systematic review (PMID:
40424522) confirms the significant long-term risk of adverse kidney outcomes after AKI episodes.
- Brenner & Rector's The Kidney
Key Concepts to Remember
| Concept | Detail |
|---|
| Baseline creatinine | Always needed for AKI diagnosis; if unavailable, KDIGO recommends back-calculating from MDRD assuming eGFR of 75 mL/min/1.73m² |
| AKD (Acute Kidney Disease) | New KDIGO term for kidney dysfunction lasting 7 days to 3 months - between AKI and CKD |
| Anuria vs. Oliguria | Anuria (<100 mL/day) suggests complete obstruction or cortical necrosis; oliguria <400 mL/day |
| "AKI on CKD" | Common scenario - these patients are at highest risk for rapid progression to ESKD |
Sources:
- Campbell-Walsh-Wein Urology
- Brenner & Rector's The Kidney, 2-Volume Set
- Harrison's Principles of Internal Medicine, 22nd Edition (2025)
- National Kidney Foundation Primer on Kidney Diseases, 8th Edition
- Tintinalli's Emergency Medicine